Clinical Trial Update: Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS)

View source ↗

Summary

A completed clinical trial evaluated heat-shock protein inhibitors in patients with myeloproliferative neoplasms, reporting on efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Drugs mentioned

• Heat-shock Protein Inhibitors

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Myeloproliferative Syndrome | Status: COMPLETED